Compositions and methods for the treatment of tumor of hematopoietic origin

Details for Australian Patent Application No. 2009213070 (hide)

Owner Genentech, Inc.

Inventors Desauvage, Frederic J.; Smith, Vicotira; Ebens Jr., Allen; Crowley, Craig; Eaton, Dan L.; Poson, Andrew

Agent Griffith Hack

Pub. Number AU-B-2009213070

Parent 2004291141

Filing date 11 September 2009

Wipo publication date 8 October 2009

Acceptance publication date 1 December 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 October 2009 Complete Application Filed

8 October 2009 Application Open to Public Inspection

  Published as AU-B-2009213070

1 December 2011 Application Accepted

  Published as AU-B-2009213070

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009213071-Catheter with adjustable deflection sensitivity

2009213069-Intravascular pressure sensor